Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Maxim licenses caspase-activating anticancer compounds to BioChem Pharma

July 11, 2000

Tumor antigen-specific chimeric proteins from Idec promote antitumor immune response

July 11, 2000

Shortened Taxol regimen approved by FDA for advanced ovarian cancer

July 11, 2000

Chemoprotective effects of KF-41399 demonstrated in nimustine-treated mice

July 11, 2000

New benzazepine selectively targets tumor cells and induces G2/M arrest and apoptosis

July 11, 2000

Angiostatin combined with radiation therapy enters phase I trials

July 11, 2000

SkyePharma grants Paladin exclusive Canadian rights for DepoCyt

July 10, 2000

Aronex files NDA amendment for Atragen as treatment for APL

July 10, 2000

Abbott licenses novel antimitotic agent from Eisai

July 10, 2000

Tamoxifen for DCIS granted FDA approval

July 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...